• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

快速起病的肌张力障碍-帕金森综合征患者的脑脊液高香草酸水平

Cerebrospinal fluid homovanillic acid levels in rapid-onset dystonia-parkinsonism.

作者信息

Brashear A, Butler I J, Hyland K, Farlow M R, Dobyns W B

机构信息

Department of Neurology, Indiana University School of Medicine, Indianapolis, USA.

出版信息

Ann Neurol. 1998 Apr;43(4):521-6. doi: 10.1002/ana.410430417.

DOI:10.1002/ana.410430417
PMID:9546335
Abstract

Rapid-onset dystonia-parkinsonism (RDP) is characterized by sudden onset over hours to days of dystonia, dysphagia, dysarthria, and parkinsonism. RDP has been reported by our group in two apparently unrelated families. We now report analysis of cerebrospinal fluid metabolites of dopamine, norepinephrine, and serotonin for mild and severely affected individuals, known asymptomatic gene carriers, and at-risk individuals from both families with RDP. Levels of the dopamine metabolite homovanillic acid (HVA) were decreased in severely affected patients and in some asymptomatic gene carriers. HVA levels increased with treatment in some affected individuals, but this increase did not predict clinical response to carbidopa/levodopa. We suggest that a low HVA level is a biological marker with modest association to the diagnosis of RDP.

摘要

快速起病性肌张力障碍-帕金森综合征(RDP)的特征是在数小时至数天内突然出现肌张力障碍、吞咽困难、构音障碍和帕金森综合征。我们团队在两个明显无亲缘关系的家族中报告过RDP。我们现在报告对来自这两个RDP家族的轻度和重度受累个体、已知的无症状基因携带者以及高危个体的脑脊液中多巴胺、去甲肾上腺素和5-羟色胺代谢物的分析。多巴胺代谢物高香草酸(HVA)水平在重度受累患者和一些无症状基因携带者中降低。在一些受累个体中,HVA水平随治疗而升高,但这种升高并不能预测对卡比多巴/左旋多巴的临床反应。我们认为低HVA水平是与RDP诊断有适度关联的生物学标志物。

相似文献

1
Cerebrospinal fluid homovanillic acid levels in rapid-onset dystonia-parkinsonism.快速起病的肌张力障碍-帕金森综合征患者的脑脊液高香草酸水平
Ann Neurol. 1998 Apr;43(4):521-6. doi: 10.1002/ana.410430417.
2
Variable phenotype of rapid-onset dystonia-parkinsonism.快速起病肌张力障碍-帕金森综合征的可变表型
Mov Disord. 1996 Mar;11(2):151-6. doi: 10.1002/mds.870110206.
3
Possible sporadic rapid-onset dystonia-parkinsonism.
Mov Disord. 2002 May;17(3):608-9. doi: 10.1002/mds.10103.
4
Diminished levels of ventricular fluid norepinephrine metabolite and somatostatin in childhood-onset dystonia.儿童期起病的肌张力障碍患者脑室液中去甲肾上腺素代谢产物和生长抑素水平降低。
Adv Neurol. 1988;50:177-81.
5
Monoamine precursors, transmitters and metabolites in cerebrospinal fluid: a prospective study in healthy male subjects.脑脊液中的单胺前体、递质和代谢产物:一项针对健康男性受试者的前瞻性研究。
J Psychiatr Res. 1996 May-Jun;30(3):201-8. doi: 10.1016/0022-3956(96)00007-6.
6
PET imaging of the pre-synaptic dopamine uptake sites in rapid-onset dystonia-parkinsonism (RDP).
Mov Disord. 1999 Jan;14(1):132-7. doi: 10.1002/1531-8257(199901)14:1<132::aid-mds1022>3.0.co;2-j.
7
[Clinical course and CSF monoamine metabolism in neuroleptic malignant syndrome--a study of nine typical cases and five mild cases].[抗精神病药恶性综合征的临床病程及脑脊液单胺代谢——9例典型病例和5例轻症病例的研究]
Seishin Shinkeigaku Zasshi. 1989;91(6):429-56.
8
A family with hereditary juvenile dystonia-parkinsonism.一个患有遗传性青少年肌张力障碍-帕金森综合征的家族。
Mov Disord. 1995 Jul;10(4):482-8. doi: 10.1002/mds.870100413.
9
Juvenile parkinsonism: a patient with possible primary striatal dysfunction.
Ann Neurol. 1978 May;3(5):453-5. doi: 10.1002/ana.410030518.
10
Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.男性和女性对照组中的脑脊液犬尿喹啉酸——与单胺代谢产物的相关性及混杂因素的影响
J Psychiatr Res. 2007 Jan-Feb;41(1-2):144-51. doi: 10.1016/j.jpsychires.2005.12.001. Epub 2006 Jan 24.

引用本文的文献

1
study of p.Ala275Pro mutant causing alternating hemiplegia of childhood and rapid-onset dystonia-parkinsonism.导致儿童交替性偏瘫和快速起病的肌张力障碍-帕金森综合征的p.Ala275Pro突变体研究
Front Neurosci. 2024 Jul 31;18:1415576. doi: 10.3389/fnins.2024.1415576. eCollection 2024.
2
Genetically altered animal models for ATP1A3-related disorders.用于 ATP1A3 相关疾病的基因改造动物模型。
Dis Model Mech. 2021 Oct 1;14(10). doi: 10.1242/dmm.048938. Epub 2021 Oct 6.
3
Update on pediatric dystonias: etiology, epidemiology, and management.
小儿肌张力障碍的最新进展:病因、流行病学及管理
Degener Neurol Neuromuscul Dis. 2012 Apr 11;2:29-41. doi: 10.2147/DNND.S16082. eCollection 2012.
4
Insights into the Pathology of the α3 Na(+)/K(+)-ATPase Ion Pump in Neurological Disorders; Lessons from Animal Models.对神经疾病中α3钠钾ATP酶离子泵病理学的见解;来自动物模型的经验教训。
Front Physiol. 2016 Jun 14;7:209. doi: 10.3389/fphys.2016.00209. eCollection 2016.
5
Distinct neurological disorders with ATP1A3 mutations.ATP1A3 突变相关的不同神经障碍。
Lancet Neurol. 2014 May;13(5):503-14. doi: 10.1016/S1474-4422(14)70011-0.
6
Psychiatric disorders in rapid-onset dystonia-parkinsonism.快速进展性肌张力障碍-帕金森病的精神障碍。
Neurology. 2012 Sep 11;79(11):1168-73. doi: 10.1212/WNL.0b013e3182698d6c. Epub 2012 Aug 29.
7
Characterization of Atp1a3 mutant mice as a model of rapid-onset dystonia with parkinsonism.快速发作性肌张力障碍伴帕金森病的 Atp1a3 突变小鼠模型的特征。
Behav Brain Res. 2011 Jan 20;216(2):659-65. doi: 10.1016/j.bbr.2010.09.009. Epub 2010 Sep 17.
8
Rapid-onset dystonia-parkinsonism: case report.快速起病的肌张力障碍-帕金森综合征:病例报告
J Neurol. 2010 Mar;257(3):472-4. doi: 10.1007/s00415-009-5385-y.